Zongxiang Yuan Selected Research

Idiopathic CD4-Positive T-Lymphocytopenia (T Lymphocytopenia, Idiopathic CD4 Positive)

7/2021

A Prognostic Model to Assess Long-Term Survival of Patients on Antiretroviral Therapy: A 15-Year Retrospective Cohort Study in Southwestern China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zongxiang Yuan Research Topics

Disease

2	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 07/2021
1	Disease Progression 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2022
1	Infections 01/2022
1	Opportunistic Infections (Opportunistic Infection) 07/2021
1	Idiopathic CD4-Positive T-Lymphocytopenia (T Lymphocytopenia, Idiopathic CD4 Positive) 07/2021

Drug/Important Bio-Agent (IBA)

1	Antiviral Agents (Antivirals)IBA 01/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	Uric Acid (Urate)IBA 01/2022
1	VaccinesIBA 01/2022
1	CytokinesIBA 01/2022
1	BilirubinIBA 07/2021
1	CreatinineIBA 07/2021
1	Hemoglobins (Hemoglobin)IBA 07/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2021